chartexchange

RCUS
Arcus Biosciences, Inc.
stockNYSE

At CloseNov 18, 2026 3:59:57 PM EST
15.77USD-3.752%(-0.62)1,973,154
Pre-marketNov 18, 2026 9:21:30 AM EST
16.35USD-0.244%(-0.04)
After-hoursNov 18, 2026 4:10:30 PM EST
15.76USD-0.095%(-0.01)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Hayward, CA, USA
Previous Close
$16.39
Beta
1.59
52-Week High
$31.74 2026-06-30
52-Week Low
$15.75 2026-11-18
SMA 50
$21.85
SMA 200
$24.39
Avg. Vol 10D
1.33M
Avg. Vol 30D
2.24M
Avg. Vol 90D
1.65M
Relative Vol
0.88
143.99M
96.69M
13,177,876
0.2500%
400
RCUS Profile

arcus biosciences is an exciting young company founded on a vision of creating new cancer therapeutics through the utilization of emerging insights in immunology. arcus was formed in 2015 by a group of seasoned researchers from the biotechnology and pharmaceutical industries and is located in the san francisco bay area, in the heart of the world's largest biotechnology research hub. unlike many other organizations, we view the drug discovery process as one that requires equal parts of technology and art, science and elegance, not as a commodity that can be outsourced. for this reason, we have assembled and are continuing to build an internal team of uniquely qualified individuals with extraordinary knowledge, skills and drive. arcus is rapidly establishing a portfolio of novel therapeutics encompassing both small molecules and biologics that target various facets of the immune system implicated in pathology or modulation of the cellular processes of cancer. these new drugs will then be

RCUS Performance
PeriodPriceDateChangeBeta
1W17.772026-11-12-11.31%0.197
1M22.142026-10-19-28.82%1.382
3M30.352026-08-19-48.07%1.389
6M22.752026-05-19-30.73%1.390
1Y20.222025-11-19-22.06%1.593
2Y14.512024-11-19+8.62%—
5Y47.552021-11-19-66.86%1.521
RCUS Stock Summary

Arcus Biosciences, Inc. (NYSE:RCUS) stock price today is $15.76, and today's volume is 1,973,154. RCUS is down 3.844% today. The 30 day average volume is 2.24M. RCUS market cap is $2.27B with 143.99M shares outstanding.